Recombinant Human CRKL Protein，His

CRKL (C-terminus of the CRK-like protein) is an adaptor protein that plays a crucial role in various cellular processes, including signal transduction, cytoskeletal organization, and cell migration. It contains two SH2 (Src Homology 2) domains and one SH3 (Src Homology 3) domain, allowing it to interact with various signaling molecules and participate in the regulation of cellular responses to external stimuli. Research into CRKL has gained momentum due to its association with several cancers, including leukemia and breast cancer, where it is often involved in the transformation and survival of malignant cells. The understanding of CRKL's molecular mechanisms and pathways is essential for developing targeted therapies. Additionally, the production and characterization of recombinant CRKL protein have become pivotal for elucidating its functional roles in signal transduction pathways. This protein can be utilized in various biochemical assays to study its interactions and regulatory mechanisms. Advances in recombinant DNA technology and protein expression systems have enabled researchers to produce high-purity CRKL, facilitating detailed structural and functional studies. By investigating the properties and interactions of CRKL, scientists aim to uncover its potential as a therapeutic target and to develop novel strategies for cancer treatment. The ongoing research into the recombinant CRKL protein underscores the importance of understanding its function in normal cellular physiology and its implications in disease progression.